GR

Green Cross Holdings

A holding company in biopharma, diagnostics, consumer, and digital healthcare.

005250 | KO

Overview

Corporate Details

ISIN(s):
KR7005250006
LEI:
Country:
South Korea
Address:
경기 용인시 구성읍 동백리 (주)녹십자 303, 용인시

Description

Green Cross Holdings is a holding company operating as a global leader in the health industry. The company's business is structured across four primary segments: Biopharma, Diagnosis, Consumer Health, and Digital Healthcare. The Biopharma division specializes in the development and manufacturing of biological medications, including blood plasma derivatives and vaccines. The Diagnosis segment offers a range of services from clinical trials to specialized testing. The Consumer Health division provides products for daily wellness, such as health functional foods and injections. The Digital Healthcare unit delivers health services through a digital platform, aiming to provide more accessible care. The company focuses on innovation in drug development and expanding its role across the healthcare spectrum from treatment to diagnostics and preventative care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-11 00:00
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Korean 6.1 KB
2024-12-11 00:00
타법인주식및출자증권취득결정(종속회사의주요경영사항)
Korean 17.7 KB
2024-11-26 00:00
타인에대한채무보증결정
Korean 21.5 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 2.7 MB
2024-11-06 00:00
[기재정정]타법인주식및출자증권처분결정
Korean 19.0 KB
2024-11-05 00:00
[기재정정]타법인주식및출자증권처분결정
Korean 19.0 KB
2024-11-04 00:00
[기재정정]타법인주식및출자증권처분결정
Korean 19.7 KB
2024-10-17 00:00
최대주주등소유주식변동신고서
Korean 90.9 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 2.8 MB
2024-08-08 00:00
최대주주등소유주식변동신고서
Korean 79.2 KB
2024-07-26 00:00
최대주주등소유주식변동신고서
Korean 86.7 KB
2024-07-17 00:00
타법인주식및출자증권처분결정
Korean 16.1 KB
2024-06-12 00:00
최대주주등소유주식변동신고서
Korean 83.2 KB
2024-05-31 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.7 KB
2024-05-31 00:00
최대주주등소유주식변동신고서
Korean 80.1 KB

Automate Your Workflow. Get a real-time feed of all Green Cross Holdings filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Green Cross Holdings

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Green Cross Holdings via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.